Código QR (código de barras bidimensional)

Persistence to Ocrelizumab Compared with Other Disease-Modifying Therapies for Multiple Sclerosis: Results from the German NeuroTransData Registry

Abstract Introduction Treatment persistence is critical to obtaining full therapeutic benefit and can indicate favorable outcomes. This study examined real-world persistence with ocrelizumab (OCR) versus other disease-modifying therapies (DMTs) and its association with outcomes in relapsing–remittin...

ver descrição completa

Na minha lista:
Principais autores: Stefan Braune, Petra Dirks, Seya Colloud, Qing Wang, Evan Davies, Yanic Heer, Mel Zürcher, Diana Sun, Arnfin Bergmann, the NeuroTransData Study Group
Formato: Artigo
Idioma:Inglês
Publicado em: Adis, Springer Healthcare 2025-06-01
coleção:Neurology and Therapy
Assuntos:
Disease-modifying therapy
Multiple sclerosis
Ocrelizumab
Patient outcomes
Persistence
Real-world setting
Acesso em linha:https://doi.org/10.1007/s40120-025-00762-6
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registros relacionados